Nuvaxovid

Nuvaxovid is the one COVID shot with zero fatal reports in Sweden's national data, but that is a passive-reporting signal, not proof of safety.

Sweden tracked over 113,800 spontaneous reports across all COVID vaccines from late 2020 to mid-2023, including 456 fatal reports [1]. Nuvaxovid had zero fatal reports, while the other brands carried them [1]. That is the strongest thing the retrieved evidence says for it. But spontaneous reporting is voluntary and catches a fraction of real events, so zero reports means zero reports, not zero deaths.

Australia's 2022 surveillance logged 948 reports naming Nuvaxovid, 848 of them where it was the suspect vaccine [2]. The country recorded 160 death reports that year and judged just 1 likely linked to any COVID vaccine [2]. Neither record breaks Nuvaxovid out by its own death or myocarditis counts, so the brand-specific harm picture is thin.

What these searches did not surface: any randomized trial of Nuvaxovid with hard outcomes like hospitalization or death, any vaccinated-versus-unvaccinated comparison, and any long-term safety follow-up. Those gaps are the search's limit, not proof they don't exist. Weigh the zero-fatality signal against the fact that nobody here measured Nuvaxovid against a true untreated group.

My call: for someone weighing Nuvaxovid specifically, the retrieved evidence shows a cleaner fatal-report profile than the other brands but cannot establish safety, because the only data is voluntary reporting. Confidence: low.